skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I know you like Knight Therapeutics. Stock has been hit quite hard recently, and currently is trading around $8. Do you think it's a good entry price here? Also is it a safe stock to hold in a RESP account? (My kids are quite young, so the money inside RESP won't be cashed for minimum 10 years.)Thanks for your great advice!
Read Answer Asked by Rebecca on March 26, 2015
Q: Hello, could we have your thoughts on the current valuation and prospects for Savaria. It is approaching 6 per cent of my portfolio which is pretty high for a company of this size I think. Thanks.
Read Answer Asked by Adam on March 24, 2015
Q: Mr. Dalsin has said in three different calls/interviews now that a dividend, by the company, is one of their milestones once they reach the 20-25 million EBITDA. Do you still consider the initiation of a dividend as being one of the strongest indicators of a company's strength?
Read Answer Asked by Kyle on March 23, 2015
Q: Hi Peter,

I have a small position in Biosyent. Admittedly it had a very good run in 2014, but has gone a bit silent in recent months despite strong numbers. Would you see this as normal consolidation or are there other issues at play. I'm a bit underwater and would appreciate your thoughts on whether to hold or to move on.

Thanks
Read Answer Asked by Greg on March 19, 2015
Q: In Johnathan Goodman's comments this morning, following release of their results, he indicated he will not rest until Knight realizes the same gains as Paladin (paraphrased). Do you see the possibility that this stock will go from $9 to $140 and was there anything in their year end results that gives a hint this is even remotely possible??
On another note, what happened to RMP Energy?
Thanks.
Read Answer Asked by Steven on March 19, 2015
Q: Hi Peter and team,

Patient Home Monitoring is a Canadian company but all or most of the business is in the US. Is the business model stable. Can you kindly let me know about the revenue and profit is stable as well. Is this a good buy because the company stock has triple in the last year. Thanks.
Read Answer Asked by Norwood on March 19, 2015
Q: Peter,
What are your thoughts on New Look's Q4 results? Earnings continue to grow, margins holding in around the 20% level. Decent dividend and despite the strong share appreciation, still seems to be 'under the radar' as no one has asked a question about the company in nearly a year. Valuation seems to be the big question mark and whether they can expand in Canada.
Thanks.
Read Answer Asked by Zach on March 18, 2015
Q: Can I have your thoughts on Lumenpulse. Thanks
Read Answer Asked by Leonard on March 18, 2015
Q: Would like to have your thoughts on new look eyeware. tks
Read Answer Asked by Albert on March 17, 2015
Q: Down on results today, is this a buying opportunity? Thanks
Read Answer Asked by richard on March 17, 2015
Q: Hello,
what do you think of guestlogix these days?
Luke
Read Answer Asked by luke on March 17, 2015
Q: What do you think of their recent earnings and of this company going forward.
Read Answer Asked by Gerard on March 17, 2015
Q: I am up over 55% in less that a week on this stock in my RRSP which has taken a hit since Dec. from Bank stock and Energy stocks with over a 30% of total portfolio. I realize I did not diversify, as I always felt safe with these type of investments.
I sold $12000 of Royal bank after the quarterly dividend and invested in Concordia which has netted me $17000.00 as of today with the stock currently off $3.72, and dropping at the moment
I am concerned that cxr will probably pull back for profit taking, however if cxr is a roll up story, like csu, would it not make sense to hold on, or should I sell half or all, and wait for a proper pull back to get back in.

I listened to the ceo of cxr about how the fundamentals of the new company are accreditive, as well as his goals going forward. Very impressive to say the least

I know 5i highlighted this company in the past, and really would appreciate your thoughts going forward

Thanks for your awesome service.
Read Answer Asked by Rick on March 16, 2015
Q: Which is riskier PLI or CRH? If you were going to invest today for a 3 year period would you go with PLI or CRH? On a valuations basis considering growth potential, is CRH still "cheap" relative to its peers even after the recent increase?
Read Answer Asked by James on March 13, 2015
Q: HI;

I'm considering adding one of these two companies to my portfolio. Which one would you prefer for growth over the next 2-3 years?

Ray
Read Answer Asked by Raymond on March 12, 2015
Q: 5i
What are your thoughts on this stock ?
The last 3-6 months have seen a significant upward trend . Do you anticipate this trend to continue ? Are earnings growth looking good over the next 1-2 years ?
Is it solid enough to invest in ?
Thanks
Bill C.
Read Answer Asked by Bill on March 12, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!